Inventor · disambiguated record
Richard John O'Reilly
Also filed as: O'REILLY RICHARD · O'REILLY RICHARD J · O'REILLY RICHARD JOHN
8 granted patents·6 pending applications·5 citations·filing 2013–2020
77Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER11SLOAN KETTERING INST CANCER2ULMERT HANS DAVID STAFFAN1
Top patents by PatentIndex Score
14 records- 0177US10100087B2Immunogenic WT-1 peptides and methods of use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Oct 16, 2018·2 cites·30 claims
- 0275US10857182B2Generation and use in adoptive immunotherapy of stem cell-like memory T cellsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Dec 8, 2020·1 cites·35 claims
- 0365US11173205B2Methods of selecting T cell line and donor thereof for adoptive cellular therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Nov 16, 2021·1 cites·17 claims
- 0464US10815274B2Immunogenic WT-1 peptides and methods of use thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Oct 27, 2020·0 cites·11 claims
- 0564US10568908B2Methods of treating Epstein-Barr virus-associated lymphoproliferative disorders by T cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Feb 25, 2020·1 cites·37 claims
- 0662US11103577B2Methods of treating CMV retinitis by T cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Aug 31, 2021·0 cites·39 claims
- 0747US2015104413A1Immunogenic wt-1 peptides and methods of use thereofSLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 0846US2021000874A1Methods of selecting t cell line for adoptive cellular therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 0943US10342864B2Methods of treating CMV retinitis by T cell therapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Jul 9, 2019·0 cites·54 claims
- 1042US2022153863A1Prame binding molecules and uses thereofULMERT HANS DAVID STAFFAN·Filed 2020·Application pending·0 cites
- 1140US12338458B2Use of the IL-15/IL-15Rα complex in the generation of antigen-specific T cells for adoptive immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jun 24, 2025·0 cites·27 claims
- 1238US2020017586A1Use of immune checkpoint modulators in combination with antigen-specific t cells in adoptive immunotherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 1335US2016152725A1Antigen-binding proteins specific for hla-a2-restricted wilms tumor 1 peptideSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
- 1431US2016375060A1Methods of Treating Glioblastoma Multiforme by T Cell TherapyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard John O'Reilly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →